Cadenza Bio

BiotechnologySeedOklahoma City, UScadenza.bio

Latest round

Seed

Last raised

Dec 2023

Total raised

$2.4M

Investors

5

About Cadenza Bio

Founded in 2022 and based in Oklahoma, US, Cadenza Bio, Inc. operates as a biotechnology company that offers small-molecule drugs for the treatment of demyelinating and inflammatory diseases. Carol Curtis (CEO) and Elaine Hamm (COO) are the co-founders of the company. In December 2023, Candeza Bio, Inc. The company focuses on advancing a range of non-steroidal compounds that target estrogen receptor ß (ERß). These compounds exhibit therapeutic efficacy in preclinical models for conditions like multiple sclerosis (MS) and endometriosis. Cadenza Bio's compounds have shown potential for reducing inflammation around affected nerves, promoting myelin repair, and improving functional recovery in preclinical animal models. The company's dual-action therapeutic medicines offer a proposition by providing neuroprotective and immunomodulatory effects, potentially slowing disease progression and allowing nervous system restoration.

Who invested in Cadenza Bio

5 investors across 1 round

See all investors in Cadenza Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Dec 14, 2023

    Amount

    $2.4M

    Investors

    Locked

Questions about Cadenza Bio

Who invested in Cadenza Bio?

Cadenza Bio has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Cadenza Bio raised?

Cadenza Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Cadenza Bio last raise money?

Cadenza Bio's most recent round on record is a Seed, in Dec 2023.

What does Cadenza Bio do?

Founded in 2022 and based in Oklahoma, US, Cadenza Bio, Inc.

Where is Cadenza Bio headquartered?

Cadenza Bio is headquartered in Oklahoma City, US.

Which VCs invest in companies like Cadenza Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cadenza Bio's stage. Their profiles are linked below.

Raising like Cadenza Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.